Prostate cancer cell type-specific regulation of the human PTHrP gene via a negative VDRE

Veronica A. Tovar Sepulveda, Miriam Falzon

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Parathyroid hormone-related protein (PTHrP) is expressed by prostate cancer cells. Since PTHrP increases the growth and enhances the osteolytic effects of prostate cancer cells, it is important to control the level of PTHrP expression in these cells. We show that 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) and its non-calcemic analogue, EB1089, suppress PTHrP mRNA and protein levels in the human prostate cancer cell lines PC-3 and LNCaP. The human PTHrP gene contains a sequence element homologous to the negative vitamin D response element within the parathyroid hormone gene. This DNA sequence (nVDREhPTHrP) bound the vitamin D receptor (VDR) present in nuclear extracts from both PC-3 and LNCaP cells. However, when cloned upstream of the SV40 promoter and transiently transfected into PC-3 and LNCaP cells, nVDREhPTHrP downregulated promoter activity in response to 1,25(OH)2D3 or EB1089 treatment in LNCaP, but not in PC-3, cells. These results may help to explain why some prostate cancers appear to be refractory to treatment with vitamin D analogues.

Original languageEnglish (US)
Pages (from-to)51-64
Number of pages14
JournalMolecular and Cellular Endocrinology
Volume204
Issue number1-2
DOIs
StatePublished - Jun 30 2003

Fingerprint

Parathyroid Hormone-Related Protein
Prostatic Neoplasms
Genes
Cells
Vitamin D Response Element
Calcitriol Receptors
Calcitriol
DNA sequences
Parathyroid Hormone
Vitamin D
Refractory materials
Sequence Homology
human PTH protein
Down-Regulation
Messenger RNA
Cell Line
Growth
Proteins

Keywords

  • 1,25-Dihydroxyvitamin D
  • EB1089
  • EMSA
  • LNCaP (prostate cancer cells)
  • Negative vitamin D response element
  • Parathyroid hormone-related protein
  • PC-3 (prostate cancer cells)
  • Promoter activity

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Prostate cancer cell type-specific regulation of the human PTHrP gene via a negative VDRE. / Tovar Sepulveda, Veronica A.; Falzon, Miriam.

In: Molecular and Cellular Endocrinology, Vol. 204, No. 1-2, 30.06.2003, p. 51-64.

Research output: Contribution to journalArticle

@article{c37aa0c99c254fb8802d2b2bc2d559c2,
title = "Prostate cancer cell type-specific regulation of the human PTHrP gene via a negative VDRE",
abstract = "Parathyroid hormone-related protein (PTHrP) is expressed by prostate cancer cells. Since PTHrP increases the growth and enhances the osteolytic effects of prostate cancer cells, it is important to control the level of PTHrP expression in these cells. We show that 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) and its non-calcemic analogue, EB1089, suppress PTHrP mRNA and protein levels in the human prostate cancer cell lines PC-3 and LNCaP. The human PTHrP gene contains a sequence element homologous to the negative vitamin D response element within the parathyroid hormone gene. This DNA sequence (nVDREhPTHrP) bound the vitamin D receptor (VDR) present in nuclear extracts from both PC-3 and LNCaP cells. However, when cloned upstream of the SV40 promoter and transiently transfected into PC-3 and LNCaP cells, nVDREhPTHrP downregulated promoter activity in response to 1,25(OH)2D3 or EB1089 treatment in LNCaP, but not in PC-3, cells. These results may help to explain why some prostate cancers appear to be refractory to treatment with vitamin D analogues.",
keywords = "1,25-Dihydroxyvitamin D, EB1089, EMSA, LNCaP (prostate cancer cells), Negative vitamin D response element, Parathyroid hormone-related protein, PC-3 (prostate cancer cells), Promoter activity",
author = "{Tovar Sepulveda}, {Veronica A.} and Miriam Falzon",
year = "2003",
month = "6",
day = "30",
doi = "10.1016/S0303-7207(03)00148-5",
language = "English (US)",
volume = "204",
pages = "51--64",
journal = "Molecular and Cellular Endocrinology",
issn = "0303-7207",
publisher = "Elsevier Ireland Ltd",
number = "1-2",

}

TY - JOUR

T1 - Prostate cancer cell type-specific regulation of the human PTHrP gene via a negative VDRE

AU - Tovar Sepulveda, Veronica A.

AU - Falzon, Miriam

PY - 2003/6/30

Y1 - 2003/6/30

N2 - Parathyroid hormone-related protein (PTHrP) is expressed by prostate cancer cells. Since PTHrP increases the growth and enhances the osteolytic effects of prostate cancer cells, it is important to control the level of PTHrP expression in these cells. We show that 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) and its non-calcemic analogue, EB1089, suppress PTHrP mRNA and protein levels in the human prostate cancer cell lines PC-3 and LNCaP. The human PTHrP gene contains a sequence element homologous to the negative vitamin D response element within the parathyroid hormone gene. This DNA sequence (nVDREhPTHrP) bound the vitamin D receptor (VDR) present in nuclear extracts from both PC-3 and LNCaP cells. However, when cloned upstream of the SV40 promoter and transiently transfected into PC-3 and LNCaP cells, nVDREhPTHrP downregulated promoter activity in response to 1,25(OH)2D3 or EB1089 treatment in LNCaP, but not in PC-3, cells. These results may help to explain why some prostate cancers appear to be refractory to treatment with vitamin D analogues.

AB - Parathyroid hormone-related protein (PTHrP) is expressed by prostate cancer cells. Since PTHrP increases the growth and enhances the osteolytic effects of prostate cancer cells, it is important to control the level of PTHrP expression in these cells. We show that 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) and its non-calcemic analogue, EB1089, suppress PTHrP mRNA and protein levels in the human prostate cancer cell lines PC-3 and LNCaP. The human PTHrP gene contains a sequence element homologous to the negative vitamin D response element within the parathyroid hormone gene. This DNA sequence (nVDREhPTHrP) bound the vitamin D receptor (VDR) present in nuclear extracts from both PC-3 and LNCaP cells. However, when cloned upstream of the SV40 promoter and transiently transfected into PC-3 and LNCaP cells, nVDREhPTHrP downregulated promoter activity in response to 1,25(OH)2D3 or EB1089 treatment in LNCaP, but not in PC-3, cells. These results may help to explain why some prostate cancers appear to be refractory to treatment with vitamin D analogues.

KW - 1,25-Dihydroxyvitamin D

KW - EB1089

KW - EMSA

KW - LNCaP (prostate cancer cells)

KW - Negative vitamin D response element

KW - Parathyroid hormone-related protein

KW - PC-3 (prostate cancer cells)

KW - Promoter activity

UR - http://www.scopus.com/inward/record.url?scp=0037769114&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037769114&partnerID=8YFLogxK

U2 - 10.1016/S0303-7207(03)00148-5

DO - 10.1016/S0303-7207(03)00148-5

M3 - Article

C2 - 12850281

AN - SCOPUS:0037769114

VL - 204

SP - 51

EP - 64

JO - Molecular and Cellular Endocrinology

JF - Molecular and Cellular Endocrinology

SN - 0303-7207

IS - 1-2

ER -